✦ LIBER ✦

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

✍ Scribed by Richard L. Heideman; Roger J. Packer; Gregory H. Reaman; Jeffrey C. Allen; Beverly Lange; Marc E. Horowitz; Seth M. Steinberg; Andrea Gillespie; Edward H. Kovnar; Frank M. Balis; David G. Poplack

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 489 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930701)72:1<271::aid-cncr2820720147>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of topotecan for ped

Phase II evaluation of topotecan for pediatric central nervous system tumors

✍ Susan M. Blaney; Peter C. Phillips; Roger J. Packer; Richard L. Heideman; Stacey 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

## BACKGROUND. Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-ho

A phase II trial of preirradiation carbo

A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system

✍ Jeffrey C. Allen; Robert C. Darosso; Bernadine Donahue; Anita Nirenberg 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Feasibility of sequential high-dose chem

Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies

✍ Jakacki, Regina I.; Jamison, Cheryl; Heifetz, Stephen A.; Caldemeyer, Karen; Han 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Background. The outlook for many brain tumors remains poor. Increased dose intensity has been correlated with response rate and survival in many solid tumors. Patients and Methods. Ten children with recurrent or newly diagnosed brain tumors were treated with four sequential courses of highdose sing

Aziridinylbenzoquinone in recurrent, pro

Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A phase ii study by the illinois cancer council

✍ Max Haid; Janardan D. Khandekar; Miriam Christ; Carole M. Johnson; Stephen J. Mi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

Central nervous system involvement at di

Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma

✍ Kaplinsky, C.; Toren, A.; Neumann, Y.; Mandel, M.; Kenet, G.; Sharon, N.; Rechav 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Central nervous system (CNS) involvement in like skin involvement with epidermolysis. A Ki-1/CD30 lymphoma is extremely rare, in con-lymph node biopsy was compatible with Ki-1/ trast to the frequent involvement in other types CD30 anaplastic large cell lymphoma (ALCL). of pediatric non-Hodgkin's lym

Cytogenetic evidence for a less malignan

Cytogenetic evidence for a less malignant leukemic cell population in the central nervous system in a critical case of acute myeloblastic leukemia

✍ Mastrangelo, Renato; Tornesello, Assunta; Mastrangelo, Stefano; Bembo, Vincenzo; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

## Background. With the exception of a single study the cytogenetic aspects of leukemic cells in the central nervous system (CNS) have not been investigated. ## Patients and Results. During the course of a work-in-progress on the chromosomal constitution both of the spinal fluid and of bone mar